Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial
S Sonalkar, N Koelper, MD Creinin, JM Atrio… - American journal of …, 2020 - Elsevier
Background Early pregnancy loss is a common event in the first trimester, occurring in 15%–
20% of confirmed pregnancies. A common evidence-based medical regimen for early …
20% of confirmed pregnancies. A common evidence-based medical regimen for early …
[HTML][HTML] Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial
S Sonalkar, N Koelper, MD Creinin… - American Journal of …, 2020 - escholarship.org
BackgroundEarly pregnancy loss is a common event in the first trimester, occurring in 15%-
20% of confirmed pregnancies. A common evidence-based medical regimen for early …
20% of confirmed pregnancies. A common evidence-based medical regimen for early …
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial
S Sonalkar, N Koelper, MD Creinin, JM Atrio… - 2020 - pubmed.ncbi.nlm.nih.gov
Background Early pregnancy loss is a common event in the first trimester, occurring in 15%-
20% of confirmed pregnancies. A common evidence-based medical regimen for early …
20% of confirmed pregnancies. A common evidence-based medical regimen for early …
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.
S Sonalkar, N Koelper, MD Creinin… - American Journal of …, 2020 - europepmc.org
Background Early pregnancy loss is a common event in the first trimester, occurring in 15%-
20% of confirmed pregnancies. A common evidence-based medical regimen for early …
20% of confirmed pregnancies. A common evidence-based medical regimen for early …
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial
S Sonalkar, N Koelper, MD Creinin… - … of obstetrics and …, 2020 - einstein.elsevierpure.com
Background: Early pregnancy loss is a common event in the first trimester, occurring in 15%–
20% of confirmed pregnancies. A common evidence-based medical regimen for early …
20% of confirmed pregnancies. A common evidence-based medical regimen for early …
[HTML][HTML] Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of success from a randomized trial
S SONALKAR, N KOELPER, MD CREININ… - American journal of …, 2020 - ncbi.nlm.nih.gov
Background: Early pregnancy loss (EPL) is a common event in the first trimester, occurring in
15–20% of recognized pregnancies. A common evidence-based medical regimen for EPL …
15–20% of recognized pregnancies. A common evidence-based medical regimen for EPL …
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial
S Sonalkar, N Koelper, MD Creinin, JM Atrio… - American Journal of …, 2020 - hero.epa.gov
Early pregnancy loss is a common event in the first trimester, occurring in 15%-20% of
confirmed pregnancies. A common evidence-based medical regimen for early pregnancy …
confirmed pregnancies. A common evidence-based medical regimen for early pregnancy …
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial
S Sonalkar, N Koelper, MD Creinin, JM Atrio… - American Journal of …, 2020 - ajog.org
Background Early pregnancy loss is a common event in the first trimester, occurring in 15%–
20% of confirmed pregnancies. A common evidence-based medical regimen for early …
20% of confirmed pregnancies. A common evidence-based medical regimen for early …